Appeals Division upholds validity of MYRTOLIN mark
G Pohl-Boskamp recently sought the invalidation of SIA Ingen Pharma’s MYRTOLIN mark, based on its own GELOMYRTOL mark. However, the Appeals Division of the Lithuanian State Patent Bureau found that the marks were dissimilar and there was thus no likelihood of confusion.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10